Wells Fargo & Company Aquestive Therapeutics, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 51,522 shares of AQST stock, worth $146,837. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,522

Previous 33,392 54.29%

Holding current value

$146,837

Previous $166,000 9.64%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$3.46 - $5.64 $62,729 - $102,253	18,130 Added 54.29%	51,522 $182,000
Q3 2024 Nov 13, 2024	BUY	$2.4 - $5.09 $2,534 - $5,375	1,056 Added 3.27%	33,392 $166,000
Q2 2024 Aug 13, 2024	BUY	$2.31 - $4.5 $19,106 - $37,219	8,271 Added 34.37%	32,336 $84,000
Q1 2024 May 10, 2024	BUY	$2.01 - $6.09 $19,581 - $59,328	9,742 Added 68.02%	24,065 $102,000
Q4 2023 Feb 09, 2024	BUY	$1.29 - $2.47 $61 - $118	48 Added 0.34%	14,323 $28,000
Q3 2023 Nov 13, 2023	BUY	$1.5 - $2.24 $60 - $89	40 Added 0.28%	14,275 $21,000
Q2 2023 Aug 15, 2023	BUY	$1.06 - $2.49 $3,025 - $7,106	2,854 Added 25.08%	14,235 $23,000
Q1 2023 May 12, 2023	BUY	$0.72 - $1.15 $2 - $4	4 Added 0.04%	11,381 $12,000
Q4 2022 Feb 13, 2023	SELL	$0.77 - $1.18 $7,691 - $11,787	-9,989 Reduced 46.75%	11,377 $10,000
Q3 2022 Nov 14, 2022	SELL	$0.63 - $1.73 $584 - $1,605	-928 Reduced 4.16%	21,366 $25,000
Q2 2022 Aug 12, 2022	BUY	$0.64 - $2.57 $124 - $498	194 Added 0.88%	22,294 $14,000
Q1 2022 May 16, 2022	BUY	$2.28 - $4.26 $2,508 - $4,686	1,100 Added 5.24%	22,100 $58,000
Q4 2021 Feb 14, 2022	SELL	$3.69 - $6.37 $605 - $1,044	-164 Reduced 0.77%	21,000 $82,000
Q3 2021 Nov 15, 2021	BUY	$3.25 - $4.66 $65 - $93	20 Added 0.09%	21,164 $93,000
Q2 2021 Aug 16, 2021	SELL	$3.29 - $5.21 $395,615 - $626,492	-120,248 Reduced 85.05%	21,144 $84,000
Q1 2021 May 13, 2021	BUY	$4.17 - $6.73 $332,561 - $536,724	79,751 Added 129.38%	141,392 $735,000
Q4 2020 Feb 09, 2021	SELL	$4.65 - $7.79 $10,560 - $17,691	-2,271 Reduced 3.55%	61,641 $330,000
Q3 2020 Nov 05, 2020	BUY	$4.12 - $9.09 $77,390 - $170,746	18,784 Added 41.62%	63,912 $310,000
Q2 2020 Aug 13, 2020	BUY	$1.84 - $6.44 $67,202 - $235,208	36,523 Added 424.44%	45,128 $219,000
Q1 2020 May 14, 2020	BUY	$1.54 - $6.75 $13,251 - $58,083	8,605 New	8,605 $19,000

Others Institutions Holding AQST

# of Institutions

121

Shares Held

43.3M

Call Options Held

504K

Put Options Held

148K

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $152M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Aquestive Therapeutics, Inc. Transaction History